Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, and Pharmaceutical Economics and Decision-Making Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Int J Health Policy Manag. 2016 Mar 5;5(5):321-4. doi: 10.15171/ijhpm.2016.24.
Injection is one of the most common medical procedures in the health sector. Annually up to 16 billion injections are prescribed in low- and middle-income countries (LMICs), many of them are not necessary for the patients, increase the healthcare costs and may result in side effects. Currently over 40% of outpatient prescriptions in Iran contain at least one injectable medicine. To address the issue, a working group was established (August 2014 to April 2015) to provide a comprehensive policy brief to be used by national decision-makers. This report is the extract of methods that were followed and the main policy options for improving injectable medicines prescribing in outpatient services. Thirty-three potential policy options were developed focusing on different stakeholders. The panel reached consensus on seven policy options, noting effectiveness, cost, durability, and feasibility of each policy. The recommended policy options are targeted at patients and public (2 policies), insurers (2), physicians (1), pharmacies (1), and the Ministry of Health and Medical Education (MoHME) (1).
注射是医疗保健领域最常见的医疗程序之一。在低收入和中等收入国家(LMICs),每年有高达 160 亿次注射,其中许多对患者来说是不必要的,增加了医疗保健成本,并可能导致副作用。目前,伊朗超过 40%的门诊处方至少含有一种注射药物。为了解决这个问题,成立了一个工作组(2014 年 8 月至 2015 年 4 月),为国家决策者提供一份全面的政策简报。本报告是所遵循的方法和改善门诊服务中注射药物处方的主要政策选择的摘录。针对不同利益相关者制定了 33 项潜在政策选择。专家组就 7 项政策选择达成共识,注意到每项政策的有效性、成本、持久性和可行性。建议的政策选择针对患者和公众(2 项政策)、保险公司(2 项)、医生(1 项)、药房(1 项)和卫生部和医学教育部(MoHME)(1 项)。